(Q44353177)

2 December 2017

title

Microcrystals for dissolution rate enhancement of poorly water-soluble drugs (English)

1 reference

2 December 2017

Norbert Rasenack

1

1 reference

2 December 2017

Helge Hartenhauer

series ordinal

2

1 reference

2 December 2017

Bernd W Müller

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

International Journal of Pharmaceutics

2 December 2017

published in

1 reference

2 December 2017

volume

254

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

137-145

1 reference

Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Pharmaceutical Applications of Solid Dispersion Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Micronization of drugs using supercritical carbon dioxide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

A comparison of the solubility of danazol in human and simulated gastrointestinal fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Ibuprofen crystals with optimized properties

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2803%2900005-X

7 January 2021

10.1016/S0378-5173(03)00005-X

Identifiers

DOI

1 reference

2 December 2017

1 reference